{"nct_id":"NCT03340766","title":"Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)","status":"COMPLETED","status_verified_date":"2024-07","start_date":"2018-03-16","start_date_type":"ACTUAL","primary_completion_date":"2020-11-06","primary_completion_date_type":"ACTUAL","completion_date":"2023-08-14","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AMGN"]}